These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8056004)

  • 1. Early and late exercise capacity after acute myocardial infarction treated with recombinant tissue-plasminogen activator.
    Brzostek T; Van de Werf F; Mortelmans L; Scheys I; Lesaffre E; Dubiel JS; De Geest H
    Eur Heart J; 1994 May; 15(5):641-7. PubMed ID: 8056004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of late administration of tissue-type plasminogen activator on left ventricular remodeling and function after myocardial infarction.
    Bonaduce D; Petretta M; Villari B; Breglio R; Conforti G; Montemurro MV; Lanzillo T; Morgano G
    J Am Coll Cardiol; 1990 Dec; 16(7):1561-8. PubMed ID: 2123907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of left ventricular function two weeks and one year after an acute myocardial infarction.
    Brzostek T; Van de Werf F; Scheys I; Mortelmans L; Aubert A; Dubiel JS; De Geest H
    Angiology; 1995 Jan; 46(1):27-36. PubMed ID: 7818154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of time required for reperfusion (thrombolysis or angioplasty, or both) and location of acute myocardial infarction on left ventricular functional reserve capacity several months later.
    Little T; Crenshaw M; Liberman HA; Battey LL; Warner R; Churchwell AL; Eisner RL; Morris DC; Patterson RE
    Am J Cardiol; 1991 Apr; 67(9):797-805. PubMed ID: 1901437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.
    Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW
    Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of late coronary thrombolysis (recombinant tissue-type plasminogen activator) in preserving left ventricular function in acute myocardial infarction.
    Villari B; Piscione F; Bonaduce D; Golino P; Lanzillo T; Condorelli M; Chiariello M
    Am J Cardiol; 1990 Dec; 66(19):1281-6. PubMed ID: 2123072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
    Langer A; Minkowitz J; Dorian P; Casella L; Harris L; Morgan CD; Armstrong PW
    J Am Coll Cardiol; 1992 Nov; 20(6):1313-7. PubMed ID: 1430680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thrombolytic therapy on exercise response during early recovery from acute myocardial infarction: a placebo controlled study.
    Svendsen JH; Madsen JK; Saunamäki KI; Grande P; Pedersen F; Clemmensen P; Ha Edersdal C; Granborg J
    Eur Heart J; 1992 Jan; 13(1):33-8. PubMed ID: 1577028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of event-free survival after hospital discharge in acute myocardial infarction treated with tissue-plasminogen activator.
    Brzostek T; Van de Werf F; Scheys I; Lesaffre E; Dubiel J; De Geest H
    Acta Cardiol; 1994; 49(1):9-24. PubMed ID: 8184642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study.
    Zaret BL; Wackers FJ; Terrin ML; Ross R; Weiss M; Slater J; Morrison J; Bourge RC; Passamani E; Knatterud G
    Am J Cardiol; 1992 Jan; 69(1):1-9. PubMed ID: 1729855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very early thrombolytic therapy in suspected acute myocardial infarction. The Thrombolysis Early in Acute Heart Attack Trial Study Group.
    Am J Cardiol; 1990 Feb; 65(7):401-7. PubMed ID: 2106252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic QRS-complex and ST-segment monitoring in acute myocardial infarction during recombinant tissue-type plasminogen activator therapy. The TEAHAT Study Group.
    Dellborg M; Riha M; Swedberg K
    Am J Cardiol; 1991 Feb; 67(5):343-9. PubMed ID: 1899776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An echographic study of left ventricular function in acute myocardial infarct undergoing thrombolysis].
    Palagi C; Mariotti R; Cecchini M; Dell'Anna R; Mengozzi G; Mariani M
    Cardiologia; 1992 Apr; 37(4):269-74. PubMed ID: 1521251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of thrombolytic therapy on the outcome of early exercise test in patients with acute myocardial infarction].
    Svendsen JH; Madsen JK; Saunamäki KI; Grande P; Pedersen FH; Clemmensen PM; Haedersdal C; Granborg J
    Ugeskr Laeger; 1994 Jul; 156(30):4352-5. PubMed ID: 8066937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarction.
    Henzlova MJ; Bourge RC; Papapietro SE; Maske LE; Morgan TE; Tauxe EL; Rogers WJ
    Am J Cardiol; 1991 Jun; 67(16):1354-9. PubMed ID: 1904189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience.
    Lesnefsky EJ; Lundergan CF; Hodgson JM; Nair R; Reiner JS; Greenhouse SW; Califf RM; Ross AM
    J Am Coll Cardiol; 1996 Aug; 28(2):331-7. PubMed ID: 8800106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction.
    Nabel EG; Topol EJ; Galeana A; Ellis SG; Bates ER; Werns SW; Walton JA; Muller DW; Schwaiger M; Pitt B
    J Am Coll Cardiol; 1991 Feb; 17(2):467-73. PubMed ID: 1825097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of thrombolytic therapy on selected parameters of left ventricular function in acute myocardial infarction].
    Wrzesiński K; Kopaczewski J; Wlazłowski R; Gawor Z; Goch JH
    Pol Arch Med Wewn; 1999 Jun; 101(6):495-502. PubMed ID: 10754735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.